Reuters logo
BRIEF-FDA Approves First Study Of Insightec's Exablate Neuro To Open The Blood-Brain Barrier In Glioblastoma Patients
November 27, 2017 / 2:14 PM / 15 days ago

BRIEF-FDA Approves First Study Of Insightec's Exablate Neuro To Open The Blood-Brain Barrier In Glioblastoma Patients

Nov 27 (Reuters) - FDA-

* FDA APPROVES FIRST STUDY OF INSIGHTEC‘S EXABLATE NEURO TO OPEN THE BLOOD-BRAIN BARRIER IN GLIOBLASTOMA PATIENTS Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below